Synexa Life Sciences
Elizabeth Ross currently serves as the Head of Business Operations at Synexa Life Sciences, where responsibilities include overseeing contracts, proposals, and strategic pricing. Prior experience includes roles as Head of Client Services, Proposals Manager, and Scientist at CPGR, where Elizabeth contributed to maintaining LCMS systems and managing sample preparation as a Senior Proteomics Technician. Additional positions include Science Teacher at Media Kids Thailand, where Elizabeth taught Chemistry and Biology, and Laboratory Assistant at the University of Cape Town, assisting with genetic transformations. Elizabeth holds a Master's degree in Medical Biochemistry, a BSc (Hons) in Cell/Cellular and Molecular Biology, and a Bachelor of Science in Microbiology and Genetics, all obtained from the University of Cape Town.
This person is not in any offices
Synexa Life Sciences
Synexa Life Sciences is a global provider of biomarker and bioanalytical services, specialising in the development, validation, and delivery of a wide range of complex and custom-designed assays. With a team of 150 across five global laboratory locations; Cape Town, London, Berlin, Turku (Finland) and Rockville (Maryland USA), we provide innovative solutions to support our customers to achieve their clinical milestones. Our main areas of expertise include biomarker identification and development, clinical bioanalysis, soluble biomarker analysis (utilising MSD, ELISA, RIA, fluorescence and luminescence-based technologies), cell biology (including flow cytometry and ELISpot) and genomic services to support clinical trials and translational studies. We pride ourselves on our deep scientific expertise and our ability to tackle complex problems, translating them into robust and reliable assays to support clinical trial sample analysis. We partner with our customers to contribute to the furtherment of scientific development and ultimately better management and treatment of human health. Synexa, improving the quality of human health through innovative biomarker and bioanalytical solutions.